LPCV earnings date and last-quarter result: P/E 2938.24. Updated 2026-07-23.
Launchpad Cadenza Acquisition Corp I (LPCV) Research Hub
Launchpad Cadenza Acquisition Corp I (LPCV) trades on NASDAQ, US in the Financial Services (Financial - Conglomerates) sector. As of 2026-10-26, shares last closed at 10.13 USD (0.00%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 2938.24, market cap 0.23B. This hub links to the full technical, earnings and options research available for LPCV.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Financial Services (Financial - Conglomerates) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 10.13 USD (0.00%) |
| 52-week range | 9.95 USD – 10.13 USD |
| Trend regime | Range |
| 14-day RSI | 85.7 (Overbought) |
| Trailing P/E | 2938.24 |
| Market cap | 0.23B |
| Dividend yield | 0.00% |
Available research for LPCV
Covered Call on LPCV: how it works, illustrative setup around the real 10.13 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on LPCV: how it works, illustrative setup around the real 10.13 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on LPCV: how it works, illustrative setup around the real 10.13 USD price, max profit/loss, breakeven and when to use it. Educational.
LPCV technical analysis: range, last 10.13 USD, RSI 85.7, 52w range 9.95 USD–10.13 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is LPCV in?
Launchpad Cadenza Acquisition Corp I (LPCV) is classified under Financial Services (Financial - Conglomerates), listed on NASDAQ, US.
Is LPCV in an uptrend or downtrend?
As of 2026-10-26, LPCV is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is LPCV's trailing P/E ratio?
LPCV's trailing P/E is 2938.24, with a market cap of 0.23B. See the earnings research page for full valuation detail.